Shanghai, 29th August 2024– Pinshan Biotechnology (Shanghai) Co., Ltd. ("Pinshan Biotech"), a pioneering force in the biopharmaceutical industry, announces the official launch of its new R&D center. The state-of-the-art facility, spanning nearly 2000 square meters across two floors, will focus on advancing core research in "Membrane Material Development" and "Chromatography Resin Development."
As the cornerstone of biopharmaceutical manufacturing, the performance and quality of membrane technology and chromatography resin have a direct impact on production costs and the quality of the final product. Acknowledging this, Pinshan Biotech has prioritized in-depth technological innovations in these processes. The opening of the new R&D center not only provides an expansive workspace for the company's research team but also significantly strengthens Pinshan Biotech's R&D capabilities and technical reserves in the field of biopharmaceutical core consumables, driving the incubation and market readiness of novel technologies and products.
"Pinshan Biotech's vision is to become a global innovative leader in biopharmaceutical process solutions," said Mr. Han Han, Chairman and CEO of Pinshan Biotech. "The establishment of this new R&D center marks a significant milestone in our journey, underscoring our unwavering commitment to research and innovation. It provides a robust platform for us to achieve technological breakthroughs and spearhead industry progress. We have established a locally-oriented R&D system aimed at creating products and technologies tailored to the Chinese and global market. We are confident that through continuous technological innovations and product optimizations, we can offer more efficient and reliable solutions to our biopharmaceutical customers, actively contributing to the self-reliance and controlled development of China's biopharmaceutical industry."
Addressing Industry Pain Points: Innovation Driving Transformation
While the modern biopharmaceutical industry has experienced robust growth in recent years, it also confronts numerous challenges that require urgent solutions. Notably, the upstream critical consumables are highly reliant on imports, leading to supply instability, extended lead times, and high costs that burden enterprises and pose significant economic constraints. These issues have become bottlenecks hindering the industry's further progress.
To tackle this situation, national policies actively guide and support the localization of bioprocess solutions, aiming to break the import monopoly and enhance the industry's autonomous control capabilities. With the continuous expansion of the biopharmaceutical market, the demand for high-performance domestic consumables has risen sharply. Unfortunately, the current domestic market participants are limited, and truly mastering core technology enterprises are scarce, a situation that urgently needs to be addressed.
Distinct from some companies that have shifted their focus, Pinshan Biotech's management team brings together seasoned experts from leading global biopharmaceutical companies. With years of deep industry experience, they possess a profound understanding of the needs and pain points of bioprocess customers. The team is committed to creating high-quality localized solutions, aiming to help the industry overcome development bottlenecks and contribute solidly to the progress and prosperity of the biopharmaceutical industry through practical actions.
Relying on a deep understanding of industry needs and the company's forward-looking strategic layout, Pinshan Biotech offers more and better choices for the biopharmaceutical industry through technological innovation and localization efforts. Not only is Pinshan Biotech dedicated to transitioning from a single product supplier to a leader in integrated process solutions, but it also persists in independent innovation amidst the long-term core monopoly of imported products in the technical field, leveraging "Made in China Intelligence" to break international technology barriers.
The company focuses on innovative research and development of underlying technologies, leveraging its robust scientific research capabilities to build a solid technical foundation. For instance, Pinshan Biotech has domestic early independent research and development experience in ceramic hydroxyapatite chromatography resin products that have been industrialized. These products strictly adhere to professional quality control management and process plans for biopharmaceuticals, achieving a stable GMP-Grade product supply with an annual capacity of 3-5 tons. Pinshan Biotech's innovative leadership is not only evident in product development but also manifested in its ability to bring richer and higher-quality choices to the industry through independent innovation and technological breakthroughs, comprehensively empowering the research, development, and production of China's biopharmaceutical industry.
Quality Foundation, Diverse Enablement,Jointly Crafting a New Era in Biopharmaceuticals
The production process of biopharmaceuticals is complex and precise, with every step from cell culture to amplification, filtration, and purification being crucial. To achieve more efficient production, Pinshan Biotech is dedicated to breaking down the boundaries between various stages of biopharmaceutical production. Through technological and methodological innovations, we provide a full range of core consumable products for biopharmaceuticals, from upstream cell culture and transfection to downstream filtration, chromatography, purification, and filling. Our goal is to meet the demands of novel processes, reduce costs, enhance quality control, and push forward frontier technologies, ushering in a new revolution in the biopharmaceutical industry.
Pinshan Biotech is locally based, with a diverse range of product lines striving to comprehensively cover cell culture, cell transfection reagents, cell counting kits, chromatography resins, as well as depth filtration, microfiltration, perfusion filtration, ultrafiltration, virus clearance filtration, and other full-line products. Our production standards strictly comply with GMP and ISO quality systems, with years of technical accumulation and industry experience forming the core competitiveness of Pinshan Biotech. We not only provide one-stop, comprehensive solutions to meet various customer needs in the biopharmaceutical production process but also continuously develop richer products and services based on a solid quality foundation to satisfy the diverse needs of the market. Meanwhile, Pinshan Biotech places great importance on the protection of independent intellectual property rights, safeguarding the commercialization and internationalization of our products and ensuring that customers can enjoy higher-quality and safer services when using our products.
Currently, the company's independently developed hollow fiber materials and membrane materials have entered the production stage, with their performance comparable to products from international leading enterprises. This not only serves as a powerful testament to Pinshan Biotech's innovation capabilities but also underscores our steadfast commitment to continuous innovation and adhering to quality promises in the future.
Looking ahead, Pinshan Biotech will uphold the development philosophy of "Exquisite Craftsmanship and Relentless Excellence," continuously increase R&D investment, deepen cooperation with top domestic and international research institutions, and boldly climb new peaks in the field of biopharmaceutical consumables. We will relentlessly explore the boundaries of innovation, empower the development of the biopharmaceutical industry, and contribute our strength to the progress of the global biopharmaceutical industry.
